New Study Reveals CPAP Therapy May Lower Parkinson’s Risk in Sleep Apnea Patients

A groundbreaking study presented at the American Academy of Neurology’s 77th Annual Meeting, which is being held from April 5 to April 9, 2025, both in San Diego and online, suggests that individuals suffering from obstructive sleep apnea are at an increased risk of developing Parkinson’s disease. However, the research also indicates that early intervention with continuous positive airway pressure (CPAP) therapy may significantly reduce this risk.

The findings highlight a crucial link between obstructive sleep apnea—a condition characterized by repeated breathing interruptions during sleep—and a heightened likelihood of Parkinson’s disease. The study underscores the potential of CPAP, a commonly prescribed treatment for sleep apnea that keeps airways open during sleep, as a preventive measure against the progression to Parkinson’s.

Date: March 2, 2025

Newsflash | Powered by GeneOnline AI

Related posts:

Virginia’s Insurance Marketplace Extends Open Enrollment Deadline: A Detailed Report Amy Schumer’s Journey with Cushing Syndrome The Fallout of the USAID Funding Freeze: Implications for Global Health and Biopharmaceutical Innovation Cryptic Antigen Identified as New Immunotherapy Target for Ovarian Cancer

Author

Mark Chiang

Ph.D in Biomedical Informatics Head of AI at GeneOnline